Sorscher Steven M, Hill Aubrey, Sorscher Eric J
Internal Medicine/Oncology Section, Washington University, Campus Box 8056, St. Louis, MO, 63110, USA.
J Cancer Res Clin Oncol. 2009 Jan;135(1):159-62. doi: 10.1007/s00432-008-0426-y. Epub 2008 May 30.
Transformation of normal cells into cells with malignant phenotypes is often the result of loss of tumor suppressor gene (TSG) function after exposure to a carcinogen.
We propose that TSGs susceptible to mutation and consequent loss of function are evolutionarily preserved in normal cell genomes so that the cells survive mutation-inducing insults and thereby evade apoptosis. While the mutations produced in TSGs confer cellular persistence and preclude apoptosis, oncogenesis is the untoward consequence. Proto-oncogenes might similarly be maintained and contain evolutionarily selected and fixed sequences susceptible to mutations (oncogene activation) that prevent cell death but ironically result in host death from malignancy.
正常细胞转变为具有恶性表型的细胞通常是在接触致癌物后肿瘤抑制基因(TSG)功能丧失的结果。
我们提出,易发生突变并导致功能丧失的TSG在正常细胞基因组中是进化保守的,这样细胞就能在诱变损伤中存活下来,从而逃避凋亡。虽然TSG中产生的突变赋予细胞持久性并阻止凋亡,但肿瘤发生却是不良后果。原癌基因可能同样得以维持,并包含进化选择和固定的易发生突变的序列(原癌基因激活),这些突变可防止细胞死亡,但具有讽刺意味的是却导致宿主因恶性肿瘤而死亡。